Myocardial infarction in diabetics: do thrombolytics help? - Syed, Uneeba
33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
17 °P sammeln
  • Broschiertes Buch

Acute coronary artery disease (CAD) is one of the main cause of death in today's world. Myocardial infarction (MI) tends to be more common among diabetic patients. One of the most effective and used (in our settings) methods of resolution of MI is administration of streptokinase (SK). This study was conducted with the aim to determine the efficacy of thrombolytic therapy in reduction of ST segment elevation in acute MI patients presenting with diabetes.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Acute coronary artery disease (CAD) is one of the main cause of death in today's world. Myocardial infarction (MI) tends to be more common among diabetic patients. One of the most effective and used (in our settings) methods of resolution of MI is administration of streptokinase (SK). This study was conducted with the aim to determine the efficacy of thrombolytic therapy in reduction of ST segment elevation in acute MI patients presenting with diabetes.
Autorenporträt
La Dra. Uneeba Syed se licenció en la Universidad Nacional de Ciencia y Tecnología. Es especialista en medicina general, endocrinología y metabolismo, profesional certificada en investigación clínica y autora de varios trabajos de investigación. Actualmente trabaja como endocrinóloga y médica asesora en un hospital de atención terciaria de Lahore (Pakistán).